Description
Over half of the revenues earned in molecular diagnostics are earned by companies marketing tests to detect infectious disease. This Kalorama Information report examines the market opportunity for those tests, the companies that sell them, trends in the market and details segment-level market sizing and forecasts.
Test Segments: Market Sizing and Forecasts
There are several segments where testing at the molecular level has thrived, including the following:
• HPV Testing
• CT/NG Testing
• Molecular Hepatitis Testing
• HIV Testing
• Hospital Acquired Infections and Sepsis Testing
• Respiratory Diseases Testing
• Mycobacteria/Tuberculosis Testing
The report does not contain information on blood banking, blood typing or NAT screen tests. These are covered in Kalorama Information’s The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 11th Edition.
Regional Distribution
For each of these segments, the report provides a breakout for the following regions:
• North America
• Europe
• Asia Pacific
• Other
Company Profiles
Companies covered in this report include:
• Abbott
• bioMérieux
• Bio-Rad
• Cepheid
• Meridian
• Qiagen
• Quidel
• Roche
Table of Contents
Chapter One: Executive Summary
The Global Infectious Disease Molecular Diagnostics Market
-
- Figure 1-1 Molecular Infectious Disease Market, 2019-2014
Test Segments
Emerging Trends Influencing the Market Landscape
Chapter Two: Developments in Molecular Infectious Disease Testing
Molecular POC: Upstart Competitors
Prospects for Molecular POC Testing for Infectious Diseases Diagnostics
-
- Table 2-1: Selected Molecular POC Platforms in the Market for Infectious Disease Testing
Increased Presence of STDs
Lyme Disease: Major IVD Leaps in with Molecular Solutions
New Fungal Infection Spotlights Mass Spec and Sequencing
Updated Influenza Guidelines from the Infectious Diseases Society of America
PCR-based Assay for Diagnosis of Bacteremia Beats Blood Cultures in Study
Meridian Acquires GenePOC
T2Bacteria Study Demonstrates Worth in Recent Study
Bruker Completes Acquisition of Majority Interest in Infectious Disease Molecular Diagnostics Company Hain Lifescience GmbH
Reimbursement Environment for Molecular Diagnostics
New Project Uses Sequencing for TB Diagnosis in Emerging Nations
Growing Microhospital Business Beckons Clinical Labs
New Eight Bacteria Gram-Negative Test Cleared by FDA
Clinical Utility of Molecular Diagnostics
AI Assisting with Molecular Colorectal Diagnosis
Chapter Three: Markets for Molecular Infectious Disease Diagnostics
-
- Table 3-1: Selected Integrated Clinical Molecular Systems in the Market for Infectious Disease Diagnostics
Market Analysis – Global
-
- Table 3-2: Market by Segments (%) (HIV and Hepatitis, Hospital, STIs and HPV, Other)
- Table 3-3: Global Molecular Infectious Disease Diagnostics Markets (2019-2024), by Infection ($, Million) (Hepatitis, HIV, HAIs/Sepsis, HPV, CT/NG, Respiratory Diseases, Mycobacteria/TB, Other, Total)
- Table 3-4: Global Molecular Infectious Disease Diagnostics Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
- CT/NG, HPV and Womenís Health
- Table 3-5: Global Molecular HPV Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
- Table 3-6: Global Molecular CT/NG Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
- Hepatitis
- Table 3-7: Global Molecular Hepatitis Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
- HIV
- Table 3-8: Innovations in Molecular POC Diagnostics for HIV
- Table 3-9: Global Molecular HIV Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
- Hospital-Acquired Infections (HAIs)
- Table 3-10: Global Molecular HAIs/Sepsis Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
- Respiratory Diseases
- Table 3-11: Global Molecular Respiratory Diseases Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
- Mycobacteria/Tuberculosis
- Table 3-12: Global Molecular Mycobacteria/TB Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
Chapter Four: Company Profiles
Abbott Diagnostics
- The Molecular Diagnostics Business Post-Acquisition of Alere
Becton, Dickinson & Co. (BD)
- Business Segments
- Molecular Diagnostics Focus
bioMerieux
Bio-Rad Laboratories
Danaher (Cepheid and Leica Biosystems)
- Life Sciences Business
- Diagnostics Business
- Cepheid
- Leica Biosystems
- Danaher’s 2018 Performance and 2019 Expectations
- Acquisitions and Divestments in 2018 / 2019
Meridian Bioscience Inc
QIAGEN N.V.
- Consumables and Related Revenues
- Automation Platform and Instrumentation
- Molecular Diagnostics Applications
- Applied Testing
- Pharma and Academia
- New Developments (in 2018 until mid-2019)
- Developments in Automation Systems
- Bioinformatics Solutions
Quidel Corporation
Roche Diagnostics
- Global Access Program for HIV
- Core Molecular
- cobas Liat System – POC
- Partnering with Information Technology
- Product Launches in 2018
